Results 181 to 190 of about 502,516 (332)
Microbial IgA Protease Removes IgA Immune Complexes from Mouse Glomeruli In Vivo: Potential Therapy for IgA Nephropathy [PDF]
Michael E. Lamm +6 more
openalex +1 more source
ABSTRACT Background Lebrikizumab is approved to treat patients with moderate‐to‐severe atopic dermatitis (AD). Objectives This study evaluated the 16‐week efficacy outcomes of lebrikizumab in adults and adolescents with severe AD in ADvocate trials who would be eligible for treatment based on South Korean reimbursement‐like criteria. Methods This was a
Chong Hyun Won +11 more
wiley +1 more source
Evaluation of a Respiratory Syncytial Virus Subunit Vaccine Candidate in IgA-Deficient Mice: Insights into the Role of IgA in Vaccine-Induced Immunity and Protection. [PDF]
Gonzalez Gonzalez L +3 more
europepmc +1 more source
ABSTRACT Multiple myeloma (MM) is a malignant plasma cell disorder that primarily presents with CRAB symptoms (calcium elevation, renal failure, anemia, and bone abnormalities). In rare cases, MM manifests with systemic complications like skin ulcers, which present management challenges. Here, we report a 78‐year‐old Japanese man with MM and refractory
Naoko Hattori +5 more
wiley +1 more source
P10 IL-16 expression in kidney biopsies from patients with SLE- and antiphosholipid syndrome- associated renal thrombotic microangiopathy and renal IgA vasculitis [PDF]
Aliisa Häyry +4 more
openalex +1 more source
This study provides an in‐depth account of patients' experiences of drainage as a symptom of hidradenitis suppurativa. The HIDE Scale© facilitates incorporation of these insights into clinical practice, supporting person‐centred approaches that enhance clinical assessment, reduce stigma, and strengthen patient–clinician communication.
Stine Thestrup Hansen +20 more
wiley +1 more source
Commensal microbe-derived butyrate enhances T follicular helper cell function to boost mucosal vaccine efficacy. [PDF]
Ko H +15 more
europepmc +1 more source

